These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 21875342

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.
    Skippen I, Shemko M, Turton J, Kaufmann ME, Palmer C, Shetty N.
    J Hosp Infect; 2006 Oct; 64(2):115-23. PubMed ID: 16859810
    [Abstract] [Full Text] [Related]

  • 23. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, Mensa J.
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [Abstract] [Full Text] [Related]

  • 24. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Wang SS, Lee NY, Hsueh PR, Huang WH, Tsui KC, Lee HC, Wu CJ, Chang CM, Huang CC, Huang CF, Ko WC.
    J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
    [Abstract] [Full Text] [Related]

  • 25. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X.
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [Abstract] [Full Text] [Related]

  • 26. Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?
    Goulenok T, Ferroni A, Bille E, Lécuyer H, Join-Lambert O, Descamps P, Nassif X, Zahar JR.
    J Hosp Infect; 2013 Aug; 84(4):294-9. PubMed ID: 23846237
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
    Cheong HS, Kang CI, Kwon KT, Heo ST, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR.
    J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
    [Abstract] [Full Text] [Related]

  • 28. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C, Gudiol C, Calatayud L, Tubau F, Domínguez MA, Pujol M, Ariza J, Gudiol F.
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [Abstract] [Full Text] [Related]

  • 29. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C, Almela M, Almirante B, Grill F, Colomina J, Molinos S, Oliver A, Fernández-Mazarrasa C, Navarro G, Coloma A, López-Cerero L, Pascual A.
    J Clin Microbiol; 2010 May; 48(5):1726-31. PubMed ID: 20181897
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand .
    Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM.
    Infect Control Hosp Epidemiol; 2008 Jan; 29(1):80-2. PubMed ID: 18171194
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.
    Nasa P, Juneja D, Singh O, Dang R, Singh A.
    Eur J Intern Med; 2012 Mar; 23(2):192-5. PubMed ID: 22284253
    [Abstract] [Full Text] [Related]

  • 35. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia.
    Memon JI, Rehmani RS, Ahmed MU, Elgendy AM, Nizami IY.
    Saudi Med J; 2009 Jun; 30(6):803-8. PubMed ID: 19526164
    [Abstract] [Full Text] [Related]

  • 36. Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Cho SY, Kang CI, Cha MK, Wi YM, Ha YE, Chung DR, Lee NY, Peck KR, Song JH, Korean Network for Study on Infectious Diseases.
    Microb Drug Resist; 2015 Aug; 21(4):463-9. PubMed ID: 25756854
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Apisarnthanarak A, Kiratisin P, Mundy LM.
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):671-4. PubMed ID: 18624669
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Park SY, Kang CI, Joo EJ, Ha YE, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.
    Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS, Kim YC, Kim MH, Song JE, Oh DH, Ahn JY, Kim SB, Kim HW, Jeong SJ, Han SH, Kim CO, Song YG, Kim JM, Choi JY.
    Arch Gerontol Geriatr; 2014 Oct; 58(1):105-9. PubMed ID: 23988261
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.